当前位置: 首页 > 期刊 > 《中国当代医药》 > 2018年第25期
编号:13277510
Th22细胞及其效应因子在自身免疫性皮肤病中的作用研究进展(5)
http://www.100md.com 2018年9月5日 《中国当代医药》 2018年第25期
     [28]Zhao L,Jiang Z,Jiang Y,et al.IL-22+CD4+T-cells in patients with active systemic lupus erythematosus[J].Exp Biol Med,2013,238(2):193-199.

    [29]Zhao L,Ma H,Jiang Z,et al.Immunoregulation therapy changes the frequency of interleukin(IL)-22+CD4+T cells in systemic lupus erythematosus patients[J].Clin Exp Immunol,2014,177(1):212-218.

    [30]Lin J,Yue LH,Chen WQ.Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus[J].Immunology,2014,79(2):131-136.

    [31]Zhong W,Jiang Y,Ma H,et al.Elevated levels of CCR6+T helper 22 cells correlate with skin and renal impairment in systemic lupus erythematosus[J].Sci Rep,2017,7(1):12962.

    [32]Esin AC,Fulya C,Ayse C,et al.IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behcet′s disease[J].Mod Rheumatol,2014,24(5):802-807.

    [33]Sugita S,Kawazoe Y,Imai A,et al.Role of IL-22-and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease[J].Immunology,2013,190(11):5799-5808.

    (收稿日期:2018-04-10 本文編辑:孟庆卿), 百拇医药(徐欣欣 孙其乐 王一汀)
上一页1 2 3 4 5